Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 24 of 24 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 10/31/20
Due: 10/31/21
Phase: N/A
Priority: Normal
Start: 11/30/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/02
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: -
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 01/31/01
End: 03/31/06
Due: 03/31/07
Phase: N/A
Priority: Normal
Start: 12/31/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 10/31/06
Due: 10/31/07
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 03/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 04/12/21
End: 10/01/22
Due: 10/01/23
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 05/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 11/30/08
Due: 11/30/09